Simple blood test could spot kidney transplant problems sooner

NCT ID NCT06026592

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing a new blood test that looks for kidney-specific DNA to detect injury or rejection after a kidney transplant. Researchers will measure these DNA markers before and after surgery in 30 patients with end-stage kidney disease. The goal is to see if the test can tell the difference between signals from the patient's own failed kidneys and the new transplanted kidney, which could lead to better monitoring of transplant health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: blood test for kidney-specific DNA markers
What this could lead to: If successful, this could lead to a simple blood test to detect kidney transplant rejection earlier and more accurately than current methods.
What could go wrong: This is a very small, early-stage study with only 30 participants. The test may not prove reliable enough for routine use, and results may not apply to all transplant patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE KIDNEY INJURY RENAL TRANSPLANTATION

Contacts and locations

Locations

Pitié-Salpétriêre Hospital
RECRUITING

Paris, Île-de-France Region, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.